Molecular actions of Ebselen—an antiinflammatory antioxidant
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akerboom, 1995, The oxidation of ebselen metabolites to thiol oxidants catalyzed by liver microsomes and perfused rat liver, Arch. Biochem. Biophys., 316, 220, 10.1006/abbi.1995.1031
Andersson, 1994, Antioxidant activity of some diarylselenides in biological systems, Free Radic. Biol. Med., 16, 17, 10.1016/0891-5849(94)90238-0
Baldew, 1992, The influence of ebselen on the toxicity of cisplatin in LLC-PK1 cells, Biochem. Pharmacol., 44, 382, 10.1016/0006-2952(92)90024-D
Beil, 1990, Interaction of the anti-inflammatory seleno-organic compound ebselen with acid secretion in isolated parietal cells and gastric H+/K+-ATPase, Biochem. Pharmacol., 40, 1997, 10.1016/0006-2952(90)90229-E
Brüne, 1991, Ebselen affects calcium homeostasis in human platelets, Biochem. Pharmacol., 41, 1805, 10.1016/0006-2952(91)90118-O
Cembrzynska-Nowak, 1992, Human lymphoid target cells for the cytokine-inducing seleno-organic compounds, Arch. Immunol. Ther. Exp. Warsz., 40, 235
Christison, 1994, Human blood cells support the reduction of LDL-associated cholesteryl ester hydroperoxides by albumin-bound ebselen, Biochem. J., 304, 341, 10.1042/bj3040341
Cotgreave, 1987, N-acetylcysteine and glutathione-dependent protective Effect of PZ 51 (ebselen) against diquat induced cytotoxicity in isolated hepatocytes, Biochem. Pharmacol., 36, 2899, 10.1016/0006-2952(87)90200-0
Cotgreave, 1988, The anti-inflammatory activity of ebselen but not thiols in experimental alveolitis and bronchiolitis, Agents Actions, 24, 313, 10.1007/BF02028288
Cotgreave, 1989, Studies on the anti-inflammatory activity of ebselen, 38, 649
Cotgreave, 1992, Characterisation and quantitation of a selenol intermediate in the reaction of ebselen with thiols, Chem.-Biol. Interactions, 84, 69, 10.1016/0009-2797(92)90121-Z
Czyrski, 1991, Mitogenic activity of selenoorganic compounds in human peripheral blood leukocytes, Experientia, 47, 95, 10.1007/BF02041265
Dimmeler, 1991, Ebselen prevents inositol (1,4,5)-trisphosphate binding to its receptor, Biochem. Pharmacol., 42, 1151, 10.1016/0006-2952(91)90303-M
Doroshow, 1986, Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents, Biochem. Biophys. Res. Commun., 135, 330, 10.1016/0006-291X(86)90981-2
Engman, 1994, Catalytic effects of glutathione peroxidase mimetics on the thiol reduction of cytochrome c, Chem.-Biol. Interactions, 93, 129, 10.1016/0009-2797(94)90092-2
Fischer, 1987, Mechanism of the catalytic reduction of hydroperoxides by ebselen: a selenium-77 NMR study, Bull. Soc. Chim. Belg., 96, 757, 10.1002/bscb.19870961006
Flohé, 1989, The selenoprotein glutathione peroxidase, 643
Gao, 1993, The effect of ebselen on polymorphonuclear leukocyte and lymphocyte migration to inflammatory reactions in rats, Immuno-pharmacology, 25, 239, 10.1016/0162-3109(93)90052-R
Gao, 1993, The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis, Int. J. Immunopharmac., 15, 793, 10.1016/0192-0561(93)90016-R
Gao, 1994, The effect of ebselen on T-lymphocyte migration to arthritic joints and dermal inflammatory reactions in the rat, Int. J. Immunopharmac., 16, 279, 10.1016/0192-0561(94)90002-7
Geiger, 1993, Seleno-peroxidase-mediated cytoprotection against the damaging effects of tert-butyl hydroperoxide on leukemia cells, Free Radic. Biol. Med., 14, 251, 10.1016/0891-5849(93)90022-M
Glass, 1989, Formation of thiocarbonyl compounds in the reaction of ebselen oxide with thiols, J. Org. Chem., 54, 1092, 10.1021/jo00266a018
Gower, 1992, Ebselen, 43, 2341
Griffiths, 1992, The selective protection afforded by ebselen against lipid peroxidation in an ROS-dependent model of inflammation, Agents Actions, 36, 107, 10.1007/BF01991237
Gustafson, 1991, Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51, Cancer Chemother. Pharmacol., 28, 228, 10.1007/BF00685517
Haenen, 1990, Mechanism of the reaction of ebselen with endogenous thiols, 37, 412
Halliwell, 1991, Drug antioxidant effects, 42, 569
Harman, 1992, Protection from oxidative damage in mouse liver cells, Toxicol. Lett., 64–65, 581, 10.1016/0378-4274(92)90235-C
Hartung, 1986, Interference with arachidonic acid metabolism suppresses experimental allergic neuritis, Ann. Neurol., 20, 168
Hatchett, 1994, Carboxy-ebselen, a potent and selective inhibitor of endothelial nitric oxide synthase, J. Physiol. Pharmacol., 45, 55
Hattori, 1994, Preferential inhibition of inducible nitric oxide synthase by ebselen, Eur. J. Pharmacol., 267, R1, 10.1016/0922-4106(94)90179-1
Hoshida, 1994, Ebselen protects against ischemia-reperfusion injury in a canine model of myocardial infarction, Am. J. Physiol., 267, H2342
Hunt, 1991, Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes, Int. J. Immunopharmacol., 13, 1019, 10.1016/0192-0561(91)90056-D
Hurst, 1989, Effects of ebselen on arachidonate metabolism by ocular and non-ocular tissues, Biochem. Pharmacol., 38, 3357, 10.1016/0006-2952(89)90634-5
Inglot, 1990, Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes, Experientia, 46, 308, 10.1007/BF01951774
Inglot, 1992, Seleno-organic compounds induce interferon and tumor necrosis factor in human but not in rat or mouse lymphoid cells, Arch. Immunol. Ther. Exp. Warsz., 40, 169
Issekutz, 1992, Effect of ebselen on polymorphonuclear leukocyte adhesion to and migration through cytokine-activated vascular endothelium, Int. J. Immunopharmacol., 14, 1383, 10.1016/0192-0561(92)90009-A
Johshita, 1990, Effects of ebselen (PZ51) on ischemic brain oedema after focal ischemia in cats, Acta Neurochir. Suppl., 51, 239
Kagan, 1992, Dihydrolipoic acid—a universal antioxidant both in the membrane and in the aqueous phase, Biochem. Pharmacol., 44, 1637, 10.1016/0006-2952(92)90482-X
Kamigata, 1986, Photochemical reaction of 2-aryl-1,2-benzisoselenazol-3(2H)-ones, Bull. Chem. Soc. Jap., 59, 2179, 10.1246/bcsj.59.2179
Kamigata, 1986, Novel ring opening reaction of 2-aryl-1,2-benzisoselenazol-3(2H)-one with thiols, Heterocycles, 24, 3027, 10.3987/R-1986-11-3027
Kamigata, 1986, Oxidation of thiols and sulfides by 2-aryl-1,2-benzisoselenazol-3(2H)-one 1-oxide, Sulfur Lett., 5, 1
Kodama, 1993, Inhibitor for restenosis after percutaneous coronary arterio-plasty, PCT Int. Appl. WO 9313,762 (Cl. A61K31/165)
Kuhl, 1985, Selective inhibition of leukotriene B4 formation by ebselen: a novel approach to antiinflammatory therapy, Agents Actions, 17, 366, 10.1007/BF01982648
Kuhl, 1986, Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S,12R-6-transisomer, Prostaglandins, 31, 1029, 10.1016/0090-6980(86)90207-8
Kühn, 1994, Involvement of 15-lipoxygenase in early stages of atherogenesis, J. Exp. Med., 179, 1903, 10.1084/jem.179.6.1903
Kühn-Velten, 1989, Optical spectral studies of ebselen interaction with cytochrome P-450 of rat liver microsomes, Biochem. Pharmacol., 38, 619, 10.1016/0006-2952(89)90207-4
Kurebayashi, 1989, Gastric cytoprotection by ebselen against the injury induced by necrotizing agents in rats, Arzneim.-Forsch./Drug Res., 39, 250
Leurs, 1990, Ebselen inhibits contractile responses of guinea-pig parenchymal lung strips, Eur. J. Pharmacol., 179, 193, 10.1016/0014-2999(90)90418-6
Leyck, 1990, Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen, Agents Actions, 30, 426, 10.1007/BF01966308
Li, 1994, Mechanism of protection of ebselen against paracetamol-induced toxicity in rat hepatocytes, Biochem. Pharmacol., 48, 1631, 10.1016/0006-2952(94)90208-9
Lin, 1994, Cytoprotection against merocyanine 540-sensitized photoinactivation of the Na+, K+-adenosine triphosphatase in leukemia cells: glutathione and selenoperoxidase involvement, Photochem. Photobiol., 59, 320, 10.1111/j.1751-1097.1994.tb05041.x
Lin, 1992, Seleno-peroxidase-mediated cytoprotection against merocyanine 540-sensitized photoperoxidation and photokilling of leukemia cells, Cancer Res., 52, 5282
Maiorino, 1988, Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ 51), Biochem. Pharmacol., 37, 2267, 10.1016/0006-2952(88)90591-6
Maiorino, 1992, Antioxidant effect of ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity, Arch. Biochem. Biophys., 295, 404, 10.1016/0003-9861(92)90534-4
Miyazawa, 1993, Elimination of plasma phosphatidylcholine hydroperoxide by a seleno-organic compound, ebselen, J. Biochem. Tokyo, 114, 588, 10.1093/oxfordjournals.jbchem.a124221
Moncada, 1993, The L-arginine-nitric oxide pathway, N. Engl. J. Med., 329, 2002, 10.1056/NEJM199312303292706
Morgenstern, 1992, Determination of the relative contributions of the diselenide and selenol forms of ebselen in the mechanism of its glutathione peroxidase-like activity, Chem.-Biol. Interactions, 84, 77, 10.1016/0009-2797(92)90122-2
Müller, 1984, A novel biologically active seleno-organic compound. I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen), Biochem. Pharmacol., 33, 3235, 10.1016/0006-2952(84)90083-2
Müller, 1985, A novel biologically active selenoorganic compound. IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes, Biochem. Pharmacol., 34, 1185, 10.1016/0006-2952(85)90493-9
Nagi, 1989, Disruption of rat hepatic microsomal electron transport chains by the selenium-containing anti-inflammatory agent ebselen, Arch. Biochem. Biophys., 269, 264, 10.1016/0003-9861(89)90108-2
Narayanaswami, 1990, Oxidative damage to mitochondria and protection by ebselen and other antioxidants, Biochem. Pharmacol., 40, 1623, 10.1016/0006-2952(90)90464-V
Niederau, 1991, Effects of the seleno-organic substance ebselen in two different models of acute pancreatitis, Pancreas, 6, 282, 10.1097/00006676-199105000-00005
Niederau, 1992, Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis, Pancreas, 7, 486, 10.1097/00006676-199207000-00011
Nikawa, 1994, Interaction of albumin-bound ebselen with rat liver glutathione S-transferase and microsomal proteins, Biochem. Mol. Biol. Int., 32, 291
Nikawa, 1994, Interaction of ebselen with glutathione S-transferase and papain in vitro, Biochem. Pharmacol., 47, 1007, 10.1016/0006-2952(94)90411-1
Noguchi, 1992, Action of ebselen as an antioxidant against lipid peroxidation, Biochem. Pharmacol., 44, 39, 10.1016/0006-2952(92)90035-H
Noguchi, 1994, Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals, Biochim. Biophys. Acta, 1213, 176, 10.1016/0005-2760(94)90024-8
Nomura, 1989, Binding of ebselen to plasma protein, 189
Ochi, 1992, Roles of glutathione and glutathione peroxidase in the protection against endothelial cell injury induced by 15-hydro-peroxyeicosatetraenoic acid, Arch. Biochem. Biophys., 294, 407, 10.1016/0003-9861(92)90704-Z
Oshita, 1994, Protective effect of ebselen on constrictive hepatic vasculature: prevention of alcohol-induced effects on portal pressure in perfused livers, J. Pharmacol. Exp. Ther., 271, 20
Parnham, 1987, Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions, Biochem. Pharmacol., 36, 3095, 10.1016/0006-2952(87)90617-4
Parnham, 1991, Pharmacology of synthetic organic selenium compounds, Prog. Drug. Res., 36, 9
Patrick, 1993, Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils, Agents Actions, 40, 186, 10.1007/BF01984060
Piasecki, 1992, Simultaneous induction of interferon gamma and tumor necrosis factor alpha by different seleno-organic compounds in human peripheral blood leukocytes, Arch. Immunol. Ther. Exp. Warsz., 40, 229
Pritsos, 1992, PZ-51 (ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity, Biochem. Pharmacol., 44, 839, 10.1016/0006-2952(92)90427-K
Reich, 1987, Organoselenium chemistry. Redox chemistry of selenocysteine model systems, J. Am. Chem. Soc., 109, 5549, 10.1021/ja00252a055
Roveri, 1994, Enzymatic and immunological measurements of soluble and membrane-bound phospholipid-hydroperoxide glutathione peroxidase, Meth. Enzymol., 203, 202, 10.1016/S0076-6879(94)33023-9
Safayhi, 1985, A novel biologically active seleno-organic compound. V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase, Biochem. Pharmacol., 34, 2691, 10.1016/0006-2952(85)90569-6
Sattler, 1994, Reduction of HDL- and LDL-associated cholesterylester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and ebselen (PZ 51), Arch. Biochem. Biophys., 309, 214, 10.1006/abbi.1994.1105
Schalkwijk, 1986, An experimental model for hydrogen peroxide-induced tissue damage, 29, 532
Schewe, 1994, Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione, Biochem. Pharmacol., 48, 65, 10.1016/0006-2952(94)90224-0
Schewe, 1991, Do 15-lipoxygenases have a common biological role?, Trends Biochem. Sci., 16, 369, 10.1016/0968-0004(91)90153-M
Schöneich, 1990, Reactivity of ebselen and related selenoorganic compounds with 1,2-dichloroethane radical cations and halogenated peroxyl radicals, Arch. Biochem. Biophys., 282, 18, 10.1016/0003-9861(90)90081-9
Scurlock, 1991, Deactivation of singlet molecular oxygen by organo-selenium compounds exhibiting glutathione peroxidase activity and by sulfur-containing homologs, Photochem. Photobiol., 54, 733, 10.1111/j.1751-1097.1991.tb02082.x
Serhan, 1991, Lipoxin generation in human whole blood: monitoring by electron-capture NICI GC/MS, 421
Sies, 1989, Metabolism and disposition of ebselen, 153
Sies, 1993, Ebselen, a selenoorganic compound as glutathione peroxidase mimic, Free Radic. Biol. Med., 14, 313, 10.1016/0891-5849(93)90028-S
Sies, 1994, Ebselen: a glutathione peroxidase mimic, Meth. Enzymol., 234, 476, 10.1016/0076-6879(94)34118-4
Steinberg, 1989, Beyond cholesterol, 320, 915
Tabuchi, 1993, Antisecretory and antiulcer effects of ebselen, a seleno-organic compound, in rats, Jap. J. Pharmacol., 61, 255, 10.1254/jjp.61.255
Tabuchi, 1994, Mechanism of the inhibition of hog gastric H+, K+-ATPase by the seleno-organic compound ebselen, Arzneim. Forsch.—Drug Res., 44, 51
Tabuchi, 1995, Ebselen, a seleno-organic compound, protects against ethanol-induced murine gastric mucosal injury in both in vivo and in vitro systems, Eur. J. Pharmacol., 272, 195, 10.1016/0014-2999(95)90819-U
Tanaka, 1989, Ebselen (PZ-51) inhibits the formation of brain edema, 173
Thomas, 1991, Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins, J. Pharmacol. Exp. Ther., 256, 1182
Thomas, 1993, Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions, J. Lipid. Res., 34, 479, 10.1016/S0022-2275(20)40739-4
Van Dyke, 1986, Inhibition of gingivitis by topical application of ebselen and rosmarinic acid, Agents Actions, 19, 376, 10.1007/BF01971261
Wagner, 1994, Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte, Biochem. Pharmacol., 48, 1137, 10.1016/0006-2952(94)90150-3
Wang, 1992, Inhibition of superoxide and nitric oxide release and protection from reoxygenation injury by ebselen in rat Kupffer cells, Hepatology, 15, 1112, 10.1002/hep.1840150623
Weitzel, 1993, Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone, J. Biol. Chem., 268, 6288, 10.1016/S0021-9258(18)53251-8
Weitzel, 1990, Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion, Biochim. Biophys. Acta, 1036, 88, 10.1016/0304-4165(90)90018-R
Wendel, 1986, A novel biologically active seleno-organic compound. VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice, Biochem. Pharmacol., 35, 2115, 10.1016/0006-2952(86)90578-2
Wendel, 1984, A novel biologically active seleno-organic compound. II. Activity of PZ 51 in relation to glutathione peroxidase, Biochem. Pharmacol., 33, 3241, 10.1016/0006-2952(84)90084-4
Wendel, 1986, Inhibition by ebselen of microsomal NADPH-cytochrome P 450-reductase in vitro but not in vivo, Biochem. Pharmacol., 35, 2995, 10.1016/0006-2952(86)90376-X
Ylä-Herttuala, 1990, Colocalisation of 15-lipoxygenase mRNA and protein with eptopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions, 87, 6952
Yoshikawa, 1993, Antioxidant therapy in digestive diseases, J. Nutr. Sci. Vitaminol. Tokyo, 39, S35, 10.3177/jnsv.39.Supplement_S35
Zembowicz, 1993, Inhibition of endothelial nitric oxide synthase by ebselen, 267, 1112
Zhang, 1994, Stabilization of purified human 5-lipoxygenase with glutathione peroxidase and superoxide dismutase, Anal. Biochem., 220, 28, 10.1006/abio.1994.1294